Where does Horus Pharma rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Horus Pharma ranks #24,481 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Horus Pharma hold?

Horus Pharma holds 11 US utility patents granted between 2017 and 2024, spanning 10 technology areas.

What is Horus Pharma's Innovation Score?

Horus Pharma has an Innovation Score of 42.8 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Horus Pharma focus on?

Horus Pharma's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents, ranking #3,434 of 6,058 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Horus Pharma's patent grant rate increasing or decreasing?

Horus Pharma's recent grant velocity is +167% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Horus Pharma's patents?

Horus Pharma's patents average 16.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Horus Pharma patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Horus Pharma

USPTO PatentsView assignee record - 11 granted patents across 10 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Horus ranks #24,481 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 10 technology areas.

#24,481
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.8/100): 16.2
avg claims per patent: +167%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24481 · Foreign Corporation #24,481 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,481/49,997
PHOTO-FINISH Higgins Research &…
CPC-FOCUS A61P · 10 areas
INNOV-PAR 42.8/100
CLAIMS-RICH 16.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +167% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Higgins Research & Development, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Horus’s 42.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (20%) Velocity 13.3 pts (31%) Breadth 11.2 pts (26%) Claim depth 9.7 pts (23%)

Qualcomm Incorporated · highest

85
Horus Pharma · this assignee

43
3D Lighting… · lowest

7

What this shows Horus's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Horus?

Each dot is one of Horus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Horus’s own 16.2 claims/patent is ABOVE the 10.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Horus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Horus's grants concentrate

Horus Pharma is a focused PatentsView assignee: 10 CPC subclasses with 45.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2017. By volume, Horus sits between Higgins Research & Development, LLC and Hybio Pharmaceutical Co., Ltd..

Horus's three-year grant acceleration

Horus Pharma shows 6 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Higgins Research…

11
Hobie Cat

11
Hohmann & Barnard

11
Home Racer

11
Huf Baolong Brett…

11
Huffy

11
Hurley Internatio…

11
Hybio Pharmaceuti…

11
Horus Pharma ◀

11

What this shows Horus holds 11 patents at rank #24,490, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Horus

By rank, the assignees closest to #24,490 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Horus's primary technology class.

Horus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Horus Pharma patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	9.1%
2018	1	9.1%
2019	1	9.1%
2021	2	18.2%
2022	3	27.3%
2023	2	18.2%
2024	1	9.1%

Which technologies does Horus Pharma patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 4

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 2

B29D - Producing Particular Articles From Plastics OR From Substances IN A Plastic State 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

Y10T - Technical Subjects Covered BY Former US Classification 2

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Horus Pharma's patent record in context - here's where to go next.

Horus Pharma's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 45.5% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #24,481 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Horus Pharma against Higgins Research & Development, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.